Omnibus appropriations signed
This article was originally published in The Tan Sheet
Executive Summary
President Bush signs H.J. Res. 2 Feb. 20, providing federal government $397.4 bil. for FY 2003. House and Senate agreed to conference report Feb. 13 (1"The Tan Sheet" Feb. 17, 2003, In Brief)...
You may also be interested in...
Omnibus spending bill
House, Senate agree to conference report on FY 2003 approps bill Feb. 13, providing $413.3 mil. for CFSAN, $426.7 mil. for CDER. Total FDA budget is $1.63 bil., including $222.9 mil. in PDUFA fees. Funding levels are similar to those in version passed by lower chamber (1"The Tan Sheet," Jan. 27, 2003, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.